The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals’ (TNXP.O), drug to manage pain related to a type of chronic condition called fibromyalgia, the company said on Friday.
August 18, 2025 - 14:49
By Pharos Investment Advisors Comments are Off
The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals’ (TNXP.O), drug to manage pain related to a type of chronic condition called fibromyalgia, the company said on Friday.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014

Copyright 2023©. All Rights Reserved